HUM vs XGN · P/E 39, rev $129.66B vs rev $55.6M
Humana Inc (HUM) versus Exagen Inc (XGN) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Exagen Inc (XGN) is a diagnostics & research company listed on US.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported XGN revenue for 2024-12-31 was $55.6M. Net income was -$15.1M. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. XGN currently screens at market cap $154.1M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. XGN currently screens at market cap $154.1M.
Not investment advice. Open the HUM and XGN stock pages for the full models.
Not investment advice.